Profile data is unavailable for this security.
About the company
Kancera AB is a Sweden-based company that develops and sells drug candidates in the field of cancer. The Company's activities are divided into two areas, namely Pharmaceutical Development and Industrial Research and Development (R&D). Pharmaceutical Development area runs such projects, as Project PFKFB3, which aims to develop a drug to combat solid tumors; and Project ROR-1, which aims to develop a drug to combat chronic lymphatic leukemia (CLL). Industrial R&D area consists of the identification of new projects of high potential and of R&D work commissioned by clients. The Company's other activities include development of cancer models and stem cell-based techniques. The Company is active through its subsidiary iNovacia, which carries out analytical development, as well as the identification, validation and further optimization of drug candidates. The Company's operations are conducted at the Karolinska Institutet Science Park in Solna, Sweden.
- Revenue in SEK (TTM)0.00
- Net income in SEK-60.35m
- Incorporated2010
- Employees5.00
- LocationKancera ABKarolinska Institutet Science ParkNanna Svartz Vag 4SOLNA 171 65SwedenSWE
- Phone+46 850126080
- Websitehttps://kancera.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vo2 Cap Holding AB (publ) | 342.81m | 3.21m | 155.63m | 103.00 | 47.97 | 0.7038 | 3.05 | 0.454 | 0.0607 | 0.0607 | 6.50 | 4.13 | 0.7493 | -- | 7.03 | 3,328,282.00 | 0.7023 | -0.2564 | 0.9347 | -0.3839 | 34.62 | 23.36 | 0.9373 | -0.2409 | -- | 1.18 | 0.1564 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
| PMD Device Solutions AB | 28.62m | -36.18m | 157.41m | 1.00 | -- | -- | -- | 5.50 | -16.69 | -16.69 | 6.34 | -4.79 | 0.9465 | -- | 57.42 | -- | -119.63 | -- | -- | -- | 58.18 | -- | -126.39 | -- | 0.0505 | -3.00 | -- | -- | -- | -- | -- | -- | -- | -- |
| Vivesto AB | 0.00 | -128.74m | 159.26m | 14.00 | -- | 0.8052 | -- | -- | -0.2414 | -0.2414 | 0.00 | 0.3676 | 0.00 | -- | -- | 0.00 | -44.66 | -- | -48.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | 64.80 | -- | -- | -- |
| Biovica International AB | 5.98m | -122.99m | 165.29m | 37.00 | -- | 1.31 | -- | 27.65 | -2.42 | -2.42 | 0.115 | 1.62 | 0.033 | -0.3053 | 8.43 | 170,800.00 | -67.80 | -42.10 | -74.69 | -46.33 | 110.09 | 277.88 | -2,057.41 | -2,149.68 | 7.10 | -- | 0.057 | -- | 65.43 | 4.44 | -84.14 | -- | -20.20 | -- |
| Lumito AB (publ) | 17.00k | -25.67m | 175.47m | 14.00 | -- | 1.83 | -- | 10,321.87 | -0.1244 | -0.1244 | 0.00008 | 0.4649 | 0.0001 | -- | 0.1491 | 1,133.33 | -21.11 | -20.77 | -23.47 | -22.38 | 70,276.65 | -- | -150,998.50 | -- | 0.928 | -167.26 | 0.0944 | -- | -- | -- | 4.56 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -44.80m | 186.30m | 8.00 | -- | 9.27 | -- | -- | -0.1651 | -0.1651 | 0.00 | 0.0556 | 0.00 | -- | -- | -- | -122.57 | -57.97 | -179.56 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1145 | -- | -- | -- | 21.54 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -37.43m | 193.71m | 11.00 | -- | 9.80 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| Kancera AB | 0.00 | -60.35m | 202.87m | 5.00 | -- | 2.16 | -- | -- | -0.7267 | -0.7267 | 0.00 | 0.7749 | 0.00 | -- | -- | 0.00 | -52.92 | -54.82 | -65.84 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
| Saniona AB | 16.84m | -95.81m | 224.70m | 23.00 | -- | -- | -- | 13.34 | -1.29 | -1.29 | 0.2263 | -0.2895 | 0.1546 | -- | 4.71 | 732,173.90 | -87.96 | -59.16 | -108.11 | -70.15 | -213.08 | -970.05 | -568.94 | -1,483.55 | -- | -3.18 | 1.44 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
| SenzaGen AB | -100.00bn | -100.00bn | 224.95m | 32.00 | -- | 3.43 | -- | -- | -- | -- | -- | 2.71 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 1.24 | -- | 0.0368 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Aqua Bio Technology ASA | 13.60m | -1.51m | 228.71m | 2.00 | -- | 10.56 | 262.58 | 16.82 | -0.1599 | -0.1599 | 0.4938 | 0.3673 | 0.3079 | 0.6548 | 9.01 | -- | -3.42 | -80.72 | -6.75 | -125.29 | 66.69 | 5.57 | -11.12 | -965.98 | 0.1044 | 0.611 | 0.7538 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
| Corline Biomedical AB | 21.37m | -4.50m | 229.95m | 13.00 | -- | 2.51 | -- | 10.76 | -0.2092 | -0.2092 | 0.9944 | 4.26 | 0.2089 | -- | 6.96 | 1,643,846.00 | -4.39 | -5.71 | -4.80 | -6.24 | 115.99 | 128.60 | -21.04 | -38.46 | -- | -235.63 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
| Thor Medical ASA | 0.00 | -5.60m | 245.78m | 1.00 | -- | 0.8932 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Arctic Bioscience AS | 33.96m | -45.80m | 246.34m | 20.00 | -- | 0.9469 | -- | 7.25 | -1.79 | -1.79 | 1.33 | 10.19 | 0.1075 | 0.7025 | 2.93 | 1,687,501.00 | -14.50 | -- | -16.61 | -- | 28.96 | -- | -134.86 | -- | 2.53 | -- | 0.0079 | -- | -1.52 | -- | -33.77 | -- | -- | -- |
| Abliva AB | 137.00k | -95.51m | 247.21m | 6.00 | -- | 2.74 | -- | 1,804.43 | -0.0904 | -0.0904 | 0.0001 | 0.067 | 0.001 | -- | 0.0034 | -- | -70.40 | -74.59 | -80.95 | -86.98 | -14,491.24 | -- | -69,714.60 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
